Dottikon Exclusive Syntheis AG

Dottikon Exclusive Synthesis AG is a prominent contract manufacturing organisation (CMO) and contract development and manufacturing organisation (CDMO) that specialises in the production of high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs). With a production facility located in Dottikon, Aargau, Switzerland, the company has been a strategic partner for the chemical, biotech, and pharmaceutical industries for over 110 years. Dottikon Exclusive Synthesis AG excels in hazardous reactions, low-temperature and high-pressure chemistry, and continuous processing, striving to optimise chemical synthesis routes while enhancing selectivities, yields, and purities, as well as minimising energy consumption, waste, and carbon dioxide emissions.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Research & Development
- Regulatory Services
- Analytical Methods Development
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Contract Development and Manufacturing (CDMO)
- Excipients
- Intermediates
- Fine Chemicals

Dottikon Exclusive Synthesis AG is dedicated to providing comprehensive solutions in chemical manufacturing and development, ensuring efficient project management and maintaining close customer communication throughout all phases. For more information, please visit dottikon.com.